Siegmund Karasch

Director/Miembro de la Junta en DEUTSCHE BIOTECH INNOVATIV AG .

59 años

Health Technology

Finance

Consumer Services

Cargos activos de Siegmund Karasch

Empresas	Cargo	Inicio	Fin
DEUTSCHE BIOTECH INNOVATIV AG	Director/Miembro de la Junta	05/07/2018	-

Empresas	Cargo	Inicio	Fin
AdrenoMed AG AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany.	Director/Miembro de la Junta	01/01/2011	01/01/2014
	Fundador	-	01/01/2014
InVivo BioTech Services GmbH InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany.	Director Ejecutivo	01/01/2001	-
	Director de Operaciones	01/01/2001	-

Hochschule für Technik und Wirtschaft Berlin

Undergraduate Degree

Internacional

Alemania

Operativa

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
DEUTSCHE BIOTECH INNOVATIV AG	Finance

Empresas privadas	2
InVivo BioTech Services GmbH InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany.	Health Technology
AdrenoMed AG AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany.	Health Technology